SG10201803321TA - Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate - Google Patents
Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionateInfo
- Publication number
- SG10201803321TA SG10201803321TA SG10201803321TA SG10201803321TA SG10201803321TA SG 10201803321T A SG10201803321T A SG 10201803321TA SG 10201803321T A SG10201803321T A SG 10201803321TA SG 10201803321T A SG10201803321T A SG 10201803321TA SG 10201803321T A SG10201803321T A SG 10201803321TA
- Authority
- SG
- Singapore
- Prior art keywords
- dimethylamino
- propionate
- dodecyl
- ddaip
- active enantiomer
- Prior art date
Links
- HSMMSDWNEJLVRY-INIZCTEOSA-N dodecyl (2s)-2-(dimethylamino)propanoate Chemical compound CCCCCCCCCCCCOC(=O)[C@H](C)N(C)C HSMMSDWNEJLVRY-INIZCTEOSA-N 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
ACTIVE ENANTIOMER OF DODECYL 2-(N,N-DIMETHYLAMINO)-PROPIONATE 2R-dodecyl 2-(N,N dimethylamino)-propionate (R-DDAIP) provides an unexpectedly improved activity in facilitating transport of a pharmaceutically active compound across biological membranes and tissues, compared to SDDAIP of the same enantiomeric purity, or racemic DDAIP. Purified S-DDAIP is also provided. FIG. 1
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41899610P | 2010-12-02 | 2010-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201803321TA true SG10201803321TA (en) | 2018-06-28 |
Family
ID=46172526
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201803321TA SG10201803321TA (en) | 2010-12-02 | 2011-11-30 | Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate |
SG2013035258A SG190199A1 (en) | 2010-12-02 | 2011-11-30 | Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2013035258A SG190199A1 (en) | 2010-12-02 | 2011-11-30 | Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate |
Country Status (19)
Country | Link |
---|---|
US (1) | US20130267562A1 (en) |
EP (1) | EP2646015B1 (en) |
JP (1) | JP6109075B2 (en) |
KR (1) | KR102004552B1 (en) |
CN (1) | CN103930105B (en) |
AU (2) | AU2011336692B2 (en) |
BR (1) | BR112013012799A8 (en) |
CA (1) | CA2817417C (en) |
CL (1) | CL2013001391A1 (en) |
CR (1) | CR20130324A (en) |
ES (1) | ES2801999T3 (en) |
IL (1) | IL226173A (en) |
MX (1) | MX2013005522A (en) |
NZ (1) | NZ609826A (en) |
PL (1) | PL2646015T3 (en) |
RU (1) | RU2679308C2 (en) |
SG (2) | SG10201803321TA (en) |
WO (1) | WO2012075107A2 (en) |
ZA (1) | ZA201304840B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014028780A2 (en) * | 2012-08-15 | 2014-02-20 | Nexmed Holdings, Inc. | Antifungal compounds and methods of use |
US8900625B2 (en) | 2012-12-15 | 2014-12-02 | Nexmed Holdings, Inc. | Antimicrobial compounds and methods of use |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6118020A (en) * | 1999-05-19 | 2000-09-12 | Nexmed Holdings, Inc. | Crystalline salts of dodecyl 2-(N,N-dimethylamino)-propionate |
US6323241B1 (en) * | 2000-01-10 | 2001-11-27 | Nexmed (Holdings) Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
DE10033853A1 (en) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermal therapeutic system, containing highly dispersed silicon dioxide in matrix or adhesive layer to promote drug permeation through the skin |
EA009024B1 (en) * | 2002-06-25 | 2007-10-26 | АКРУКС ДиДиЭс ПиТиУай ЭлТиДи | Pharmaceutical composition for transdermal delivery of an active agent (variants) |
US20050181030A1 (en) * | 2003-01-03 | 2005-08-18 | Mo Y. J. | Topical stabilized prostaglandin E compound dosage forms |
PL2106805T3 (en) * | 2003-03-21 | 2011-10-31 | Nexmed Holdings Inc | Antifungal nail coat and method of use |
WO2005009510A2 (en) * | 2003-07-23 | 2005-02-03 | The Regents Of The University Of California | Penetration enhancer combinations for transdermal delivery |
EP1670433B1 (en) * | 2003-10-10 | 2011-11-23 | Antares Pharma IPL AG | Transdermal pharmaceutical formulation for minimizing skin residues |
WO2005051960A2 (en) * | 2003-11-22 | 2005-06-09 | Midwest Research Laboratories, Llc | Hydrocarbyl aminohydrocarbonoates and aminohydrocarbonol hydrocarbonoates as antimicrobial and antiviral agents |
AU2011249043B2 (en) * | 2010-05-04 | 2015-07-09 | Nexmed Holdings, Inc. | Compositions of small molecule therapeutics |
US8900625B2 (en) * | 2012-12-15 | 2014-12-02 | Nexmed Holdings, Inc. | Antimicrobial compounds and methods of use |
-
2011
- 2011-11-30 MX MX2013005522A patent/MX2013005522A/en unknown
- 2011-11-30 CA CA2817417A patent/CA2817417C/en not_active Expired - Fee Related
- 2011-11-30 AU AU2011336692A patent/AU2011336692B2/en not_active Ceased
- 2011-11-30 CN CN201180054224.5A patent/CN103930105B/en not_active Expired - Fee Related
- 2011-11-30 EP EP11845087.3A patent/EP2646015B1/en active Active
- 2011-11-30 SG SG10201803321TA patent/SG10201803321TA/en unknown
- 2011-11-30 RU RU2013119439A patent/RU2679308C2/en not_active Application Discontinuation
- 2011-11-30 JP JP2013542128A patent/JP6109075B2/en not_active Expired - Fee Related
- 2011-11-30 KR KR1020137013227A patent/KR102004552B1/en active IP Right Grant
- 2011-11-30 PL PL11845087T patent/PL2646015T3/en unknown
- 2011-11-30 NZ NZ609826A patent/NZ609826A/en not_active IP Right Cessation
- 2011-11-30 ES ES11845087T patent/ES2801999T3/en active Active
- 2011-11-30 SG SG2013035258A patent/SG190199A1/en unknown
- 2011-11-30 US US13/991,111 patent/US20130267562A1/en not_active Abandoned
- 2011-11-30 WO PCT/US2011/062579 patent/WO2012075107A2/en active Application Filing
- 2011-11-30 BR BR112013012799A patent/BR112013012799A8/en not_active Application Discontinuation
-
2013
- 2013-05-05 IL IL226173A patent/IL226173A/en active IP Right Grant
- 2013-05-16 CL CL2013001391A patent/CL2013001391A1/en unknown
- 2013-06-26 CR CR20130324A patent/CR20130324A/en unknown
- 2013-06-28 ZA ZA2013/04840A patent/ZA201304840B/en unknown
-
2017
- 2017-01-17 AU AU2017200314A patent/AU2017200314A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2011336692B2 (en) | 2017-02-16 |
JP2014514243A (en) | 2014-06-19 |
WO2012075107A3 (en) | 2014-03-06 |
BR112013012799A8 (en) | 2018-01-09 |
CN103930105A (en) | 2014-07-16 |
CA2817417C (en) | 2020-12-29 |
AU2017200314A1 (en) | 2017-02-02 |
IL226173A (en) | 2016-10-31 |
EP2646015A2 (en) | 2013-10-09 |
CL2013001391A1 (en) | 2013-11-08 |
RU2013119439A (en) | 2015-01-10 |
KR20140023875A (en) | 2014-02-27 |
RU2679308C2 (en) | 2019-02-07 |
IL226173A0 (en) | 2013-07-31 |
BR112013012799A2 (en) | 2016-09-13 |
EP2646015A4 (en) | 2015-04-08 |
NZ609826A (en) | 2016-03-31 |
CN103930105B (en) | 2019-11-01 |
MX2013005522A (en) | 2013-07-17 |
CA2817417A1 (en) | 2012-06-07 |
ES2801999T3 (en) | 2021-01-15 |
US20130267562A1 (en) | 2013-10-10 |
WO2012075107A2 (en) | 2012-06-07 |
SG190199A1 (en) | 2013-06-28 |
JP6109075B2 (en) | 2017-04-05 |
PL2646015T3 (en) | 2020-11-30 |
ZA201304840B (en) | 2014-04-30 |
CR20130324A (en) | 2013-08-13 |
EP2646015B1 (en) | 2020-04-22 |
KR102004552B1 (en) | 2019-10-01 |
AU2011336692A1 (en) | 2013-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
USD831829S1 (en) | Dental implant reusable bite registration post | |
USD659247S1 (en) | Dental implant | |
GEP20135919B (en) | Benzoic acid (1-phenyl-2-pyridin-4-yl) ethyl esters as phosphodiesterase inhibitors | |
WO2007139933A3 (en) | Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof | |
ZA201004694B (en) | Use of a fertilizer containing l-amino acid for improving root growth and growth of mycorrhiza | |
EP2590655A4 (en) | Compounds and methods for inhibiting phosphate transport | |
GEP20146100B (en) | Novel phenylimidazole derivative as pde10a enzyme inhibitor | |
WO2012006474A3 (en) | Compounds and methods for inhibiting phosphate transport | |
RS53521B1 (en) | Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide | |
WO2008073138A3 (en) | Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors | |
USD811211S1 (en) | Catheter package | |
MX2009006288A (en) | New process for the synthesis of 7,8-dimethoxy-1,3-dihydro-2h-3-b enzazepin-2-one, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid. | |
USD653879S1 (en) | Table | |
MX2012007590A (en) | Composition for improving brain function and method for improving brain function. | |
MX2009012472A (en) | Combination comprising pyrrolidone-5-carboxylic acid and at least one compound from citrulline, arginine and asparagine, and use thereof in the treatment of atopic dermatitis. | |
AR078283A1 (en) | ORAL SUSPENSION FORMULATIONS OF DIBENZAZEPINA CARBOXAMIDAS | |
USD673458S1 (en) | Package face | |
WO2013019091A3 (en) | A COMPOUND FOR INHIBITING 11β-HYDROXY STEROID DEHYDROGENASE 1, AND A PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | |
SG141358A1 (en) | Treatment of psychiatric patients with reduced heptaic function with paliperidone | |
SG10201803321TA (en) | Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate | |
HRP20060079A2 (en) | Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate | |
IL209583A0 (en) | 1 - (2-ethyl-butyl) - cyclohexanecarboxylic acid ester as an intermediate in the preparation of pharmaceutically active amides | |
USD648957S1 (en) | Triple plant holder | |
USD617054S1 (en) | Rugby jumper support grip | |
RS53896B1 (en) | Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases |